What is the preoperative risk assessment for an 87-year-old female with hypertension, a grade 3 systolic murmur (mitral valve disease), and left-sided pneumonia undergoing wide excision with possible split-thickness skin graft of the left leg?

Preoperative Risk Evaluation for 87-Year-Old Female with Hypertension, Grade 3 Mitral Murmur, and Left-Sided Pneumonia

This patient requires urgent treatment of her active pneumonia before proceeding with surgery, followed by comprehensive cardiac evaluation of her mitral valve disease to determine if she can safely undergo the planned wide excision with possible skin graft.

Immediate Priority: Active Pneumonia

The presence of active left-sided pneumonia is a critical contraindication to elective or semi-urgent surgery. The pneumonia must be treated and resolved before proceeding with the skin surgery 1. Active pulmonary infection significantly increases perioperative mortality and morbidity, particularly in an 87-year-old patient.

Action Steps:

• Initiate appropriate antibiotic therapy immediately
• Obtain chest X-ray to document extent of pneumonia
• Delay surgery until pneumonia is clinically and radiographically resolved
• Reassess respiratory status before rescheduling surgery

Cardiac Risk Stratification

Step 1: Determine Surgical Risk Category

Wide excision with possible split-thickness skin graft is classified as intermediate-risk surgery (estimated cardiac risk 1-5%) 2, 3. This requires formal preoperative cardiac evaluation given the patient's age (>45 years) and cardiac findings 1.

Step 2: Evaluate the Grade 3 Mitral Systolic Murmur

This murmur requires urgent echocardiographic evaluation before surgery 2, 4. A grade 3/6 systolic murmur suggests potentially significant mitral valve disease (either mitral regurgitation or less commonly mitral stenosis).

Critical determinations needed:

• Severity of valve disease (mild, moderate, or severe)
• Symptom status (NYHA class I-IV)
• Left ventricular function (ejection fraction, chamber dimensions)
• Presence and severity of pulmonary hypertension (pulmonary artery systolic pressure)
• Right ventricular function

Transthoracic echocardiography is mandatory before proceeding with surgery 4, 5.

Step 3: Risk Assessment Based on Valve Severity

If severe mitral stenosis is present:

• Symptomatic severe mitral stenosis generally requires valve intervention before elective noncardiac surgery 6, 7
• Asymptomatic severe mitral stenosis with favorable hemodynamics may proceed with surgery under careful monitoring 8

If severe mitral regurgitation is present:

• Symptomatic patients or those with LV dysfunction may require stabilization with intensive medical therapy before surgery 6
• Surgery can proceed if patient is asymptomatic with preserved LV function, but requires enhanced perioperative monitoring 4

If moderate valve disease:

• Generally can proceed with surgery after medical optimization 4

Step 4: Assess for Pulmonary Hypertension

Given the patient's age and valve disease, pulmonary hypertension must be evaluated via echocardiography 2.

If pulmonary hypertension is present:

• Pulmonary artery systolic pressure >70 mmHg with moderate or greater RV dysfunction represents high perioperative risk 2
• Preoperative evaluation by a pulmonary hypertension specialist is beneficial unless risks of delay outweigh benefits 2
• Continue any chronic pulmonary vasodilator therapy perioperatively 2
• Pulmonary hypertension is NOT an absolute contraindication but requires careful perioperative management 8

Calculate Perioperative Cardiac Risk

Use the Revised Cardiac Risk Index (RCRI) 2, 3:

Risk factors present in this patient:

1. Age >70 years (implied risk factor)
2. Hypertension (likely)
3. Potentially significant valvular heart disease (grade 3 murmur - pending echo confirmation)

Additional RCRI factors to assess:

• History of ischemic heart disease
• History of heart failure
• History of cerebrovascular disease
• Diabetes requiring insulin
• Preoperative creatinine >2.0 mg/dL

Risk stratification:

• 0-1 risk factors: Low risk (0.4-1% cardiac event rate)
• 2 risk factors: Intermediate risk (2.4-7% cardiac event rate)
• ≥3 risk factors: High risk (>11% cardiac event rate)

This patient likely has at least 2-3 risk factors, placing her in the intermediate to high-risk category 2.

Hypertension Management

Continue antihypertensive medications perioperatively 9:

• Beta-blockers must be continued if patient is already on them to prevent rebound hypertension 9, 10
• ACE inhibitors/ARBs may be held on the morning of surgery to prevent intraoperative hypotension 9
• Never abruptly discontinue beta-blockers or clonidine - this causes harmful rebound hypertension 9

If blood pressure is ≥180/110 mmHg:

• Consider deferring surgery to optimize blood pressure control, especially given her high-risk profile 9
• Stage 3 hypertension should be controlled before elective surgery 11

Additional Preoperative Testing Required

Mandatory:

1. 12-lead ECG - to assess for ischemia, arrhythmias, conduction abnormalities 3
2. Transthoracic echocardiogram - to characterize valve disease severity 4, 5
3. Complete metabolic panel - assess renal function (creatinine), electrolytes
4. Complete blood count - assess for anemia (increases perioperative risk) 12
5. Chest X-ray - document pneumonia resolution before surgery

Consider based on findings:

• BNP/NT-proBNP if heart failure suspected
• Pulmonary function tests given pneumonia history
• Cardiology consultation for risk stratification and perioperative management recommendations

Functional Capacity Assessment

Determine if patient can achieve ≥4 METs (metabolic equivalents) of activity 2, 1:

• Can she climb 2 flights of stairs?
• Can she walk 4 blocks on level ground?
• Can she do heavy housework?

Poor functional capacity (<4 METs) with intermediate-risk surgery and ≥2 cardiac risk factors may warrant stress testing 2, though this should be weighed against surgical urgency.

Decision Algorithm for Proceeding with Surgery

STOP - Do NOT proceed if:

• Active pneumonia is present (current status)
• Severe symptomatic aortic or mitral stenosis is confirmed on echo 6, 7
• Unstable cardiac condition (acute MI, unstable angina, decompensated heart failure)
• Blood pressure ≥180/110 mmHg uncontrolled 9

PAUSE - Optimize before proceeding if:

• Moderate to severe valve disease with symptoms - optimize with medical therapy 8
• Severe pulmonary hypertension - consider specialist consultation 2
• Poorly controlled hypertension - optimize over days to weeks 11

PROCEED with enhanced monitoring if:

• Pneumonia is fully resolved
• Mild to moderate valve disease, asymptomatic
• Blood pressure controlled
• No unstable cardiac conditions
• Patient has reasonable functional capacity

Perioperative Management Recommendations

Intraoperative considerations for mitral valve disease 4:

• For mitral regurgitation: Avoid bradycardia and excessive afterload; maintain forward flow
• For mitral stenosis: Maintain sinus rhythm, avoid tachycardia, preserve preload, prevent abrupt afterload reduction
• Consider invasive hemodynamic monitoring if severe valve disease
• Have vasopressors and inotropes readily available

Postoperative monitoring:

• Continuous cardiac monitoring for 24-48 hours minimum
• Serial troponins if high risk
• Aggressive pulmonary toilet given pneumonia history
• Early mobilization when stable

Critical Pitfalls to Avoid

1. Do NOT proceed with surgery while pneumonia is active - this is the most immediate risk to address
2. Do NOT assume the murmur is benign - grade 3/6 murmurs often represent significant pathology requiring echo evaluation
3. Do NOT abruptly stop beta-blockers or clonidine perioperatively 9, 10
4. Do NOT start beta-blockers on day of surgery if patient is beta-blocker naïve 9
5. Do NOT delay necessary surgery indefinitely for cardiac optimization if valve disease is mild-moderate and asymptomatic 8

Frailty and Life Expectancy Considerations

At age 87, assess for marked frailty and limited life expectancy 8. If the patient has:

• End-stage organ dysfunction
• Poor functional status
• Poor nutritional status
• Unlikely to see symptomatic benefit from surgery

Then the intervention may be futile and watchful waiting may be more appropriate than high-risk surgery 8.

Summary of Immediate Actions

1. Treat pneumonia aggressively - delay surgery until resolved
2. Order transthoracic echocardiogram - characterize valve disease
3. Obtain 12-lead ECG, labs (CBC, CMP, BNP)
4. Calculate RCRI score with available data
5. Request cardiology consultation for perioperative risk stratification
6. Optimize blood pressure if ≥180/110 mmHg
7. Continue chronic cardiac medications (especially beta-blockers)
8. Reassess surgical timing after pneumonia resolution and cardiac evaluation complete